Scientists gain ground against resistance

Article • Infection control

Scientists gain ground against resistance

The mechanism by which drug-resistant bacteria maintain a defensive barrier has been identified by researchers at England’s University of East Anglia (UEA) and their findings could result in a new wave of drugs that can bring down those defensive walls rather than attack the bacteria – thus they may not develop drug-resistance at all.

Report: Mark Nicholls

Gram-negative bacteria are among the most difficult to control because they are so resistant to antibiotics.

Prof. Changjiang Dong

Diamond Light Source technology, which generates extremely intense pin-point beams of synchrotron light enables scientists to explore almost any material in atomic detail, and thus to investigate Gram-negative bacteria. The latter are particularly resistant to antibiotics because of the cells’ impermeable lipid-based outer membrane, the barrier that defends against attacks from the human immune system and antibiotic drugs.

It allows the pathogenic bacteria to survive, but the loss of the barrier causes them to become more vulnerable and die. Previously the researchers had found an Achilles heel in the defence barrier but how this cell wall is built and maintained – the ‘assembly machinery’ – remained unknown.

Lead researcher Professor Changjiang Dong, from UEA’s Norwich Medical School explained: ‘Gram-negative bacteria are among the most difficult to control because they are so resistant to antibiotics. All Gram-negative bacteria have a defensive cell wall. Beta-barrel proteins form the gates of the cell wall for importing nutrition and secreting important biological molecules.’

The beta-barrel assembly machinery (BAM) is responsible for building the gates (beta-barrel proteins) in the cell wall. Dong confirmed that stopping the beta-barrel assembly machine from building the gates in the cell wall would cause the bacteria to die.

The research - funded by the Wellcome Trust with collaborators including Dr Neil Paterson of Diamond Light Source (UK), Dr Phillip Stansfield from the University of Oxford, and Professor Wenjan Wang of Sun Yat-sen University – saw scientists study the gram-negative bacteria E. coli, in which the beta-barrel assembly machinery contains five sub-units, known as BamA, BamB, BamC, BamD and BamE.

Changjiang Dong is Professor of Molecular Medicine at the University of East Anglia’s Norwich Medical School.

The researchers wanted to know exactly how these sub-units work together to insert the outer membrane proteins into the outer membrane or cell wall. Dong: ‘Our research shows the whole beta-barrel assembly machinery structures in two states - the starting and finishing states. We found that the five sub-units form a ring structure and work together to perform outer membrane protein insertion using a novel rotation and insertion mechanism… Our work is the first to show the entire BAM complex. It paves the way for developing new-generation drugs.

‘The beta-barrel assembly machinery is absolutely essential for Gram-negative bacteria to survive. The sub-unit BamA is located in the outer membrane and exposed to the outer side of the bacteria, which provides a great target for new drugs.’

In human mitochondria, he pointed out, a similar complex – called sorting and assembly machinery complex (SAM) – is responsible for building the proteins in the outer membrane of mitochondria. The research team also believe that unravelling this mechanism could lead to better understanding of human cell dysfunctions linked to disorders such as diabetes, Parkinson’s and other neurodegenerative diseases.

Changjiang Dong is Professor of Molecular Medicine at the University of East Anglia’s Norwich Medical School. His research into antibiotic resistance was named ‘Research Project of the Year’ at the Times Higher Education (THE) Awards 2015. Last year he received a Wellcome Trust Investigator Award for £1.7 million to continue his research.


Read all latest stories

Related articles


News • Potency against multidrug-resistant bacteria

Synthetic antibiotic shows promise against serious chronic infections

A new synthetic antibiotic developed by University of Liverpool researchers is shown to be more effective than established drugs against ‘superbugs’ such as MRSA, a new study shows.


News • MTX in the mix

Researchers develop novel therapy for vancomycin-resistant infections

Researchers from the US, Singapore and Geneva have developed a novel combination therapy using an anticancer agent for treating vancomycin-resistant Enterococcus faecalis (VRE).


News • Infectious disease research

Hidden bacteria increases risk of antimicrobial resistant infection in hospital patients

Carriers of a specific bacteria have a 14% chance of developing an antibiotic resistant infection with 30 days of hospitalisation, according to new research from Amsterdam.

Subscribe to Newsletter